Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab

Patients (pts) with asymptomatic low-burden follicular lymphoma (FL) are usually observed at diagnosis. Time to lymphoma treatment (TLT) initiation can however be very heterogeneous and risk factors of progression are poorly studied. Our study evaluated 201 pts with grade 1–3a low-tumor burden FL di...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodier, Cyrielle, Kanagaratnam, Lukshe, Morland, David, Herbin, Adélie, Durand, Amandine, Chauchet, Adrien, Choquet, Sylvain, Colin, Philippe, Casasnovas, René Olivier, Deconinck, Eric, Godard, François, Delmer, Alain, Rossi, Cédric, Durot, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146112/
https://www.ncbi.nlm.nih.gov/pubmed/37125257
http://dx.doi.org/10.1097/HS9.0000000000000861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146112/
https://www.ncbi.nlm.nih.gov/pubmed/37125257
http://dx.doi.org/10.1097/HS9.0000000000000861

Ejemplares similares